Hyaluronic Acid
INCI: Sodium hyaluronate
Hyaluronic Acid (sodium hyaluronate) is a glycosaminoglycan naturally found in skin, joints, and connective tissue. In gummy formats it is most commonly used in beauty and nutricosmetics ranges for skin hydration and elasticity, often paired with Collagen and Vitamin C. HA itself has no authorised EU health claim under Reg. 432/2012; claim coverage derives from co-formulated nutrients.
- Skin hydration
- Beauty stacks
- Joint comfort
At a glance
- Definition
- Hyaluronic Acid (sodium hyaluronate) is a glycosaminoglycan naturally found in skin, joints, and connective tissue. In gummy formats it is most commonly used in beauty and nutricosmetics ranges for skin hydration and elasticity, often paired with Collagen and Vitamin C. HA itself has no authorised EU health claim under Reg. 432/2012; claim coverage derives from co-formulated nutrients.
- Common gummy positionings
- Skin hydration and beauty
- Joint comfort
- Healthy ageing
- Premium nutricosmetics
- Format suitability
- Suitable for gummy formats — confirmed per project.
What it is
Hyaluronic Acid (sodium hyaluronate) is a glycosaminoglycan naturally found in skin, joints, and connective tissue. In gummy formats it is most commonly used in beauty and nutricosmetics ranges for skin hydration and elasticity, often paired with Collagen and Vitamin C. HA itself has no authorised EU health claim under Reg. 432/2012; claim coverage derives from co-formulated nutrients.
For private-label brands, hyaluronic acid is a premium active in beauty gummy ranges.
Why brands use Hyaluronic Acid in gummies
Hyaluronic Acid is one of the most familiar and commercially understood actives in its category across EU and US markets. Pairs naturally with Collagen and Vitamin C for beauty stacks (synergistic in collagen formation); with Biotin and Zinc for hair-skin-nails; with Glucosamine for joint positioning.
Consumer-perceived effective dose: 80–200 mg per daily serving for skin positioning. Gummy formats handle this comfortably. DAT reviews wording per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012.
Gummy formulation notes
Verified formulation reference. Final formulation, dose and on-pack copy are confirmed per project.
- Gummy fit
- Good
- Heat stable
- Yes
- Soluble in matrix
- Yes
- Cost tier
- High
Forms available
- Sodium hyaluronate (low / medium / high molecular weight)
- Hyaluronic acid + collagen complexes
Dosage reference
Consumer-perceived effective dose: 80–200 mg per daily serving for skin positioning. Gummy formats handle this comfortably.
Taste & sensory
Effectively tasteless at typical gummy doses.
Manufacturing notes
Fermentation-derived sodium hyaluronate is the standard for vegan-positioned ranges. Low-molecular-weight HA is absorbed more efficiently; medium/high MW positions for skin barrier support. Vegan / kosher / halal positioning depends on the selected raw material and supplier documentation — confirmed per project.
EU-authorised health claims
EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.
Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.
Wording to avoid on pack copy
- No disease claims — do not state or imply that Hyaluronic Acid cures, prevents, or treats osteoarthritis or any other disease.
- Avoid 'reverses wrinkles' or 'restores joint cartilage' as definitive structural claims in EU consumer-facing copy. HA has no authorised EU health claim; claim coverage from Vitamin C (for collagen formation) or Biotin (for skin).
- No certification promises (vegan / kosher / halal / organic) on pack until per-project and per-batch supplier documentation is confirmed.
- No guaranteed shelf-life on pack until confirmed per project with stability data.
Hyaluronic Acid has no authorised health claims under Reg. 432/2012. Substantiated 'normal skin' messaging in HA gummies is achieved via co-formulated Vitamin C using its authorised collagen-formation claim.
Studies & evidence
External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.
Oe M, Sakai S, Yoshida H et al.·Clinical, Cosmetic and Investigational Dermatology·2017
European Commission·EUR-Lex·2012
Gummies featuring Hyaluronic Acid
Private-label gummy concepts where Hyaluronic Acid appears in the formula. Each opens to a product brief and quote route.
Hyaluronic Glow Gummies
Hyaluronic Glow Gummies is a white-label gummy concept for brands building a beauty & skin range. Final positioning, claims and documentation are reviewed per project and target market.
Radiance & Youth Gummies
Radiance & Youth Gummies is a white-label gummy concept for brands building a beauty & skin range. Final positioning, claims and documentation are reviewed per project and target market.
Sleep & Skin Recovery Gummies
Sleep & Skin Recovery Gummies is a white-label gummy concept for brands building a beauty & skin range. Final positioning, claims and documentation are reviewed per project and target market.
Collagen Gummies
Collagen Gummies is a white-label gummy concept for brands building a beauty & skin range. Final positioning, claims and documentation are reviewed per project and target market.
Synergies & conflicts
Pairs well with
Pairs naturally with Collagen and Vitamin C for beauty stacks (synergistic in collagen formation); with Biotin and Zinc for hair-skin-nails; with Glucosamine for joint positioning.
Care when combining with
Generally safe and well-tolerated; rare allergic reactions in chicken-comb-derived HA — fermentation-derived HA avoids this concern.
Build a formula with Hyaluronic Acid
Hand the brief over to the DAT portal. The wizard pre-fills the ingredient, target market, and route so the project review starts with the right context.
References
- Oral hyaluronan relieves wrinkles: A double-blinded, placebo-controlled study — Oe M, Sakai S, Yoshida H et al., Clinical, Cosmetic and Investigational Dermatology, 2017.
- Commission Regulation (EU) No 432/2012 — European Commission, EUR-Lex, 2012.